Neuropathology and Applied Neurobiology

Papers
(The median citation count of Neuropathology and Applied Neurobiology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Invited Review: The spectrum of neuropathology in COVID‐1991
Intracerebral endotheliitis and microbleeds are neuropathological features of COVID‐1986
Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool56
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies50
Neuropathological findings in two patients with fatal COVID‐1950
Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models47
Systematic review of human post‐mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease37
NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence32
Classification of diseases with accumulation of Tau protein31
Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis31
Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies30
Cell senescence in neuropathology: A focus on neurodegeneration and tumours30
A case series of Diffuse Glioneuronal Tumours with Oligodendroglioma‐like features and Nuclear Clusters (DGONC)27
Identification of intraneuronal amyloid beta oligomers in locus coeruleus neurons of Alzheimer’s patients and their potential impact on inhibitory neurotransmitter receptors and neuronal excitability24
Distinct brain‐derived TDP‐43 strains from FTLD‐TDP subtypes induce diverse morphological TDP‐43 aggregates and spreading patterns in vitro and in vivo23
White matter alterations in Alzheimer’s disease without concomitant pathologies22
Impaired brain insulin signalling in Parkinson's disease21
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies21
CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma21
STochastic Optical Reconstruction Microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain21
MRI and pathology correlations in the medulla in sudden unexpected death in epilepsy (SUDEP): a postmortem study20
Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration20
A polyphenotypic malignant paediatric brain tumour presenting a MN1‐PATZ1 fusion, no epigenetic similarities with CNS High‐Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET‐MN119
Review: Microglia in motor neuron disease19
N‐terminal heterogeneity of parenchymal and vascular amyloid‐β deposits in Alzheimer’s disease19
A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies19
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson’s disease dementia18
Invited Review – Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials18
Heterozygous CAPN3 missense variants causing autosomal‐dominant calpainopathy in seven unrelated families18
Correlations in post‐mortem imaging‐histopathology studies of sporadic human cerebral small vessel disease: A systematic review18
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer’s disease18
Differential brain region‐specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey‐white matter variation17
TDP43 proteinopathy is associated with aberrant DNA methylation in human amyotrophic lateral sclerosis17
Novel CAPN3 variant associated with an autosomal dominant calpainopathy17
Plectin dysfunction in neurons leads to tau accumulation on microtubules affecting neuritogenesis, organelle trafficking, pain sensitivity and memory16
Neutrophil extracellular traps (NETs) infiltrate haematoma and surrounding brain tissue after intracerebral haemorrhage: A post‐mortem study16
Olfactory bulb SARS‐CoV‐2 infection is not paralleled by the presence of virus in other central nervous system areas16
NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature15
Spinal manifestations of CLN1 disease start during the early postnatal period15
Molecular pathophysiology of human MICU1 deficiency15
Vimentin citrullination probed by a novel monoclonal antibody serves as a specific indicator for reactive astrocytes in neurodegeneration15
Signs of early cellular dysfunction in multiple system atrophy15
Neurodegenerative movement disorders: An epigenetics perspective and promise for the future14
The autophagy‐enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease14
Intranuclear inclusions in skin biopsies are not limited to neuronal intranuclear inclusion disease but can also be seen in oculopharyngodistal myopathy14
A rare case of paediatric astroblastoma with concomitant MN1GTSE1 and EWSR1PATZ1 gene fusions altering management14
Non‐coding regulatory elements: Potential roles in disease and the case of epilepsy14
The S1PR2‐CCL2‐BDNF‐TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia14
Robust methylation‐based classification of brain tumours using nanopore sequencing14
Necrosome‐positive granulovacuolar degeneration is associated with TDP‐43 pathological lesions in the hippocampus of ALS/FTLD cases14
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency13
TRAPPC11‐related muscular dystrophy with hypoglycosylation of alpha‐dystroglycan in skeletal muscle and brain13
Lipid alterations in human frontal cortex in ALS‐FTLD‐TDP43 proteinopathy spectrum are partly related to peroxisome impairment13
Expression pattern of perilipins in human brain during aging and in Alzheimer's disease12
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second‐generation subtypes12
MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis12
Accurate calling of KIAA1549‐BRAF fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data12
Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration12
Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β‐amyloid‐toxicity12
RAPGEF2 mediates oligomeric Aβ‐induced synaptic loss and cognitive dysfunction in the 3xTg‐AD mouse model of Alzheimer’s disease12
G protein‐coupled receptor kinases are associated with Alzheimer's disease pathology12
L‐DOPA regulates α‐synuclein accumulation in experimental parkinsonism11
Concomitant LATE‐NC in Alzheimer's disease is not associated with increased tau or amyloid‐β pathological burden11
Tumour‐associated CD204+ microglia/macrophages accumulate in perivascular and perinecrotic niches and correlate with an interleukin‐6‐enriched inflammatory profile in glioblastoma11
DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population‐based study11
Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology11
Balloon cells promote immune system activation in focal cortical dysplasia type 2b11
Protein homeostasis in LGMDR9 (LGMD2I) – The role of ubiquitin–proteasome and autophagy–lysosomal system11
Global microRNA profiling identified miR‐10b‐5p as a regulator of neurofibromatosis 1 (NF1)‐glioma migration10
CD47 promotes the proliferation and migration of adamantinomatous craniopharyngioma cells by activating the MAPK/ERK pathway, and CD47 blockade facilitates microglia‐mediated phagocytosis10
Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options10
Heterozygous APOE Christchurch in familial Alzheimer’s disease without mutations in other Mendelian genes10
HnRNP K mislocalisation in neurons of the dentate nucleus is a novel neuropathological feature of neurodegenerative disease and ageing10
The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas10
Arteriolar neuropathology in cerebral microvascular disease10
Old age genetically confirmed frontotemporal lobar degeneration with TDP‐43 has limbic predominant TDP‐43 deposition10
Invited Review – A 5‐year update on epigenome‐wide association studies of DNA modifications in Alzheimer’s disease: progress, practicalities and promise10
Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies10
Telomeric alterations in the default mode network during the progression of Alzheimer’s disease: Selective vulnerability of the precuneus9
MOBP and HIP1 in multiple system atrophy: New α‐synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis9
Irisin treatment lowers levels of phosphorylated tau in the hippocampus of pre‐symptomatic female but not male htau mice9
Cauda equina paragangliomas express HOXB139
Myositis with sarcoplasmic inclusions in Nakajo–Nishimura syndrome: a genetic inflammatory myopathy9
BRAIN UK: Accessing NHS tissue archives for neuroscience research9
Targeted next‐generation sequencing of adult gliomas for retrospective prognostic evaluation and up‐front diagnostics9
Neuron types in the primate striatum: Stereological analysis of projection neurons and interneurons in control and parkinsonian monkeys9
Extracellular matrix remodelling is associated with muscle force increase in overloaded mouse plantaris muscle9
ALK‐rearranged histiocytosis: Report of two cases with involvement of the central nervous system9
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review9
Seizure activity and brain damage in a model of focal non‐convulsive status epilepticus9
Sex differences in the neuropathological hallmarks of Alzheimer’s disease: focus on cognitively intact elderly individuals9
AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD53638
Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis8
The blood–CSF–brain route of neurological disease: The indirect pathway into the brain8
The desmin mutation R349P increases contractility and fragility of stem cell‐generated muscle micro‐tissues8
Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis8
Systemic delivery of human GlyR IgG antibody induces GlyR internalization into motor neurons of brainstem and spinal cord with motor dysfunction in mice8
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics8
Characterisation of early ultrastructural changes in the cerebral white matter of CADASIL small vessel disease using high‐pressure freezing/freeze‐substitution8
Post‐treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation8
Brain TDP‐43 pathology in corticobasal degeneration: Topographical correlation with neuronal loss8
Neuropathology of genetically defined malformations of cortical development—A systematic literature review8
Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis8
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma8
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology8
Prodromal sensory neuropathy in Pink1−/−SNCAA53T double mutant Parkinson mice8
Morphological differences between dementia with Lewy bodies and Parkinson's disease‐dementia7
Ataxic phenotype and neurodegeneration are triggered by the impairment of chaperone‐mediated autophagy in cerebellar neurons7
Delineating selective vulnerability of inhibitory interneurons in Alpers' syndrome7
Blinded review of hippocampal neuropathology in sudden unexplained death in childhood reveals inconsistent observations and similarities to explained paediatric deaths7
Automated immunofluorescence analysis for sensitive and precise dystrophin quantification in muscle biopsies7
Extracellular tau oligomers affect extracellular glutamate handling by astrocytes through downregulation of GLT‐1 expression and impairment of NKA1A2 function7
Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative 7
Pathological substrate of memory impairment in multiple system atrophy7
Expression, prognostic significance and therapeutic implications of PD‐L1 in gliomas7
The severity of behavioural symptoms in FTD is linked to the loss of GABRQ‐expressing VENs and pyramidal neurons7
Cutaneous sensory and autonomic denervation in progressive supranuclear palsy7
Gonadotroph tumours with a low SF‐1 labelling index are more likely to recur and are associated with enrichment of the PI3K‐AKT pathway7
Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types7
Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia7
Alpha adaptins show isoform‐specific association with neurofibrillary tangles in Alzheimer's disease6
Live‐imaging of revertant and therapeutically restored dystrophin in the DmdEGFP‐mdx mouse model for Duchenne muscular dystrophy6
Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF‐1‐positive sellar lesions6
Early changes in visuospatial episodic memory can help distinguish primary age‐related tauopathy from Alzheimer’s disease6
Spatial molecular profiling of a central nervous system low‐grade diffusely infiltrative tumour with INI1 deficiency featuring a high‐grade atypical teratoid/rhabdoid tumour component6
Inflammation, fibrosis and skeletal muscle regeneration in LGMDR9 are orchestrated by macrophages6
An autopsy case of pure nigropathy with TUBA4A nonsense mutation6
Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation6
Identifying cellular signalling molecules in developmental disorders of the brain: Evidence from focal cortical dysplasia and tuberous sclerosis6
TGF‐β activates pericytes via induction of the epithelial‐to‐mesenchymal transition protein SLUG in glioblastoma6
A spontaneous missense mutation in the chromodomain helicase DNA‐binding protein 8 (CHD8) gene: a novel association with congenital myasthenic syndrome6
Genetic knockdown of Klk8 has sex‐specific multi‐targeted therapeutic effects on Alzheimer’s pathology in mice6
CircRNA SRRM4 affects glucose metabolism by regulating PKM alternative splicing via SRSF3 deubiquitination in epilepsy6
Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion6
Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model6
The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review6
Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours6
Met166‐Glu168 residues in human PrP β2‐α2 loop account for evolutionary resistance to prion infection6
Pathogenic variants of Valosin‐containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells5
Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges5
Primary age‐related tauopathy in a Finnish population‐based study of the oldest old (Vantaa 85+)5
Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC5
Plectin‐related scapuloperoneal myopathy with treatment‐responsive myasthenic syndrome5
Caspase‐6‐cleaved tau is relevant in Alzheimer's disease and marginal in four‐repeat tauopathies: Diagnostic and therapeutic implications5
A simple novel approach for detecting blood–brain barrier permeability using GPCR internalization5
Cytoplasmic HDAC4 recovers synaptic function in the 3×Tg mouse model of Alzheimer's disease5
Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α‐XBP1 pathway5
Paediatric astroblastoma‐like neuroepithelial tumour of the spinal cord with a MAMLD1‐BEND2 rearrangement5
GAB1 overexpression identifies hedgehog‐activated anterior skull base meningiomas5
Intrathecal amyloid‐beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's disease5
Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue5
Optimised tissue clearing minimises distortion and destruction during tissue delipidation5
Cortical morphometric vulnerability to generalised epilepsy reflects chromosome‐ and cell type‐specific transcriptomic signatures5
Novel naturally occurring autoantibodies attenuate α‐synuclein pathology in a mouse model of Parkinson's disease4
Identification of the calpain‐generated toxic fragment of ataxin‐3 protein provides new avenues for therapy of Machado–Joseph disease| Spinocerebellar ataxia type 34
The molecular characteristics of low‐grade and high‐grade areas in desmoplastic infantile astrocytoma/ganglioglioma4
Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS4
Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease4
Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A (GRN) vs Type B (C9orf72)4
Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1‐G93A transgenic mice4
MicroRNA‐34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis4
Nanoscale reorganisation of synaptic proteins in Alzheimer's disease4
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma4
Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice4
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis4
Novel autophagic vacuolar myopathies: Phenotype and genotype features4
IDH clonal heterogeneity segregates a subgroup of non‐1p/19q codeleted gliomas with unfavourable clinical outcome4
Myeloid cell subpopulations compensate each other for Ccr2‐deficiency in glioblastoma4
A TOR1AIP1 variant segregating with an early onset limb girdle myasthenia—Support for the role of LAP1 in NMJ function and disease4
CD8 T‐cell‐mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer3
Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification3
The interaction of insoluble Amyloid‐β with soluble Amyloid‐β dimers decreases Amyloid‐β plaque numbers3
Lack of difference between amyloid‐beta burden at gyral crests and sulcal depths in diverse neurodegenerative diseases3
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment3
Review: Protein misfolding diseases – the rare case of Marinesco‐Sjögren syndrome3
The analysis of epidermal nerve fibre spatial distribution improves the diagnostic yield of skin biopsy3
The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases3
CuII(atsm) significantly decreases microglial reactivity in patients with sporadic amyotrophic lateral sclerosis3
Long‐standing multiple system atrophy‐Parkinsonism with limbic and FTLD‐type α‐synuclein pathology3
m6A mRNA methylation in human brain is disrupted in Lewy body disorders3
TDP‐43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann‐Pick C disease3
What to do with unusual TDP‐43 proteinopathy cases?3
Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP‐43 inclusions and ageing‐related tau astrogliopathy in a family with a GBE1 mutation3
Identification of a novel heterozygous DYSF variant in a large family with a dominantly‐inherited dysferlinopathy3
MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 13
N471D WASH complex subunit strumpellin knock‐in mice display mild motor and cardiac abnormalities and BPTF and KLHL11 dysregulation in brain tissue3
Atypical astroglial pTDP‐43 pathology in astroglial predominant tauopathy3
Novel therapeutic targets in epilepsy: oxidative stress and iron metabolism3
Hippocampal subfield pathologic Burden in Lewy body diseases versus Alzheimer’s disease3
Target formation in muscle fibres indicates reinnervation – A proteomic study in muscle samples from peripheral neuropathies2
Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel–Lindau disease‐related tumours2
Muscle biopsy practices in the evaluation of neuromuscular disease: A systematic literature review2
Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers2
Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality‐dependent prognostic patterns2
Is leucodystrophy really a feature of PIGT‐CDG?2
Image‐based deep learning reveals the responses of human motor neurons to stress and VCP‐related ALS2
A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma2
Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals2
TAPPing into the potential of inducible tau/APP transgenic mice2
Neurotherapeutic implications of sense and respond strategies generated by astrocytes and astrocytic tumours to combat pH mechanical stress2
Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS‐mutant neurocutaneous melanosis2
Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reason2
Different patterns of hippocampal subfield pathology in Lewy body disease and Alzheimer's disease2
Genetic inhibition of PDK1 robustly reduces plaque deposition and ameliorates gliosis in the 5×FAD mouse model of Alzheimer's disease2
Progressive hemispheric atrophy in HIV: A Rasmussen's‐like variant of CD8 encephalitis?2
WNT‐activated, MYC‐amplified medulloblastoma displaying intratumoural heterogeneity2
Parkinsonism in C9orf72 expansion without co‐existing Lewy body pathology; a case report and review of the literature2
Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT12
0.031337976455688